| Ytd | -91.04% | |
| 1y | -96.91% |
| Open | 0.04 | Prev Close | 0.03 | Low | 0.03 | High | 0.05 | Mkt Cap | 1.60M |
| Vol | 49.30M | Avg Vol | 16.33M | EPS | -0.72 | P/E | -0.04 | Forward P/E | -2.70 |
| Beta | 3.37 | Short Ratio | 0.46 | Inst. Own | 8.99% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-15 | 50-d Avg | 0.21 | 200-d Avg | 0.52 | 1yr Est | 7.50 |
ITRM News
US stocks rise on Tuesday, with NASDAQ up 2% and Dow up 1.37%. Communication services shares gain 2.
US stocks higher, Dow up 0.90%, Nasdaq up 1.61%. Communication services gained 1.8%, utilities fell
PMGC Holdings shares surged 100.6% to $3.35 in pre-market trading after announcing a licensing agree
Iterum Therapeutics said on Friday it has filed a petition in Ireland's High Court to wind up the d
DUBLIN and CHICAGO, March 27, 2026 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (in Provisional Liqui
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 900 points on Tues
Shares of Ouster Inc (NASDAQ:OUST) rose sharply in pre-market trading after the company reported bet
--Expanded Market Access and Patent Protection for ORLYNVAH™ --FDA correspondence regarding the use
DUBLIN and CHICAGO, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “C
DUBLIN and CHICAGO, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “C
DUBLIN and CHICAGO, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “C
DUBLIN, Ireland and CHICAGO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM
Iterum Therapeutics plc ( ITRM ) Q3 2025 Earnings Call November 14, 2025 8:30 AM EST Company Partici
- -Commercially Launched ORLYNVAH ™ in the United States in August 2025-- --Extended Cash Runway int
Here's a look at this week's earnings reports that are most likely to be watched by retail i
DUBLIN, Ireland and CHICAGO, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM
DUBLIN and CHICAGO, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Co
DUBLIN and CHICAGO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (Iteru
FDA-approved antibiotic with the power of a penem in a novel oral formulation, offering a vital alte
ITRM Reports Results
Iterum Therapeutics plc (NASDAQ:ITRM ) Q2 2025 Earnings Conference Call August 5, 2025 8:30 AM ET Co
- - Launch of ORLYNVAH TM Expected August 2025— - -Cash Runway into 2026-- --Company to host confere
DUBLIN, Ireland and CHICAGO, July 29, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM
DUBLIN and CHICAGO, July 02, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (“Iteru
DUBLIN and CHICAGO, June 30, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (“Iteru
9.2% of Patients in REASSURE's Primary Population had a Baseline Pathogen Resistant to Three or More
Wall Street slumped into negative territory late in the week as renewed fears over inflation and tra
Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quart
Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $
Companies Reporting Before The Bell • KVH Industries (NASDAQ:KVHI) is projected to report quarterly
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings
Gainers